SCPHARMACEUTICALS INC (SCPH)
US8106481059 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 46.81M | 71.10M | 74.30M | 71.80M | 72.60M | |||
| Marketable Securities | 29.20M | 47.10M | 1.00M | 33.30M | N/A | |||
| Receivables | 4.49M | N/A | N/A | N/A | 300.00K | |||
| Inventories | 8.84M | 1.20M | N/A | N/A | N/A | |||
| Other Current Assets | 3.60M | 3.90M | 3.00M | 2.70M | 2.70M | |||
| Total Current Assets | 92.94M | 123.30M | 78.30M | 107.80M | 75.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.46M | 600.00K | 500.00K | 900.00K | 1.30M | |||
| Other Non-Current Assets | 82.00K | 300.00K | 300.00K | 300.00K | 300.00K | |||
| Total Non-Current Assets | 1.54M | 900.00K | 700.00K | 1.20M | 1.70M | |||
| TOTAL ASSETS | 94.48M | 124.20M | 79.00M | 109.00M | 77.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 9.80M | 2.40M | 0.00 | |||
| Accrued Expenses | 9.08M | 5.80M | 4.50M | 5.20M | 4.00M | |||
| Accounts Payable | 4.00M | 1.50M | 500.00K | 1.70M | 1.10M | |||
| Other Current Liabilities | 56.00K | 100.00K | 0.00 | 0.00 | 0.00 | |||
| Total Current Liabilities | 13.13M | 7.40M | 14.80M | 9.30M | 5.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 38.81M | 36.80M | 7.40M | 16.90M | 18.90M | |||
| Other Non-Current Liabilities | 5.32M | 7.60M | 400.00K | 700.00K | 1.80M | |||
| Total Non-Current Liabilities | 44.13M | 44.40M | 7.80M | 17.60M | 20.70M | |||
| TOTAL LIABILITIES | 57.26M | 51.80M | 22.60M | 26.90M | 25.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -281.35M | -226.50M | -189.70M | -161.70M | -129.50M | |||
| Additional Paid In Capital | 318.56M | 298.90M | 246.20M | 243.80M | 180.80M | |||
| Common Shares | 4.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.00K | 0.00 | 0.00 | 0.00 | N/A | |||
| Shares Outstanding | 35.97M | 34.30M | 27.40M | 27.30M | 19.40M | |||
| Tangible Book Value per Share | 1.03 | 2.11 | 2.06 | 3.01 | 2.65 | |||
| Total Shareholders' Equity | 37.22M | 72.40M | 56.50M | 82.20M | 51.40M | |||
| TOTAL LIABILITIES AND EQUITY | 94.48M | 124.20M | 79.00M | 109.00M | 77.30M | |||
| Statistics | ||||||||
| Debt/Equity | 1.04 | 0.51 | 0.13 | 0.21 | 0.37 | |||
| Current Ratio | 7.08 | 16.66 | 5.29 | 11.59 | 14.54 | |||
| Return On Assets (ROA) | -58.01% | -29.66% | -35.48% | -29.55% | -42.69% | |||
| Return On Equity (ROE) | -147.27% | -50.88% | -49.61% | -39.18% | -64.20% | |||
All data in USD